Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology
Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology
Severe SARS-CoV-2 infection, responsible of COVID-19, is accompanied by many venous
 thromboembolic events. Antithrombotic treatment is the cornerstone of management of many
 neurovascular diseases (NVDs) and the benefit-risk ratio is crucial to avoid hemorrhagic
 complications. Therefore, in non-severe COVID-19 patients affected by NVDs, the diagnostic of
 deep venous thrombosis (DVT) is challenging. Using bedside Doppler ultrasonography (DUS) of
 lower limbs, this study investigated the rates of DVT in these patients in stroke unit.
-  Inclusion criteria:

 -  Age>18 years

 -  COVID-19 confirmed with RT-PCER and/or chest CT-scan

 -  Acute neurovascular disease defined as transient ischemic attack or acute
 ischemic stroke or venous cerebral thrombosis or hemorrhagic stroke.

 -  Exclusion criteria:

 -  age<18

 -  Other neurovascular diseases